Knee osteoarthritis: hyaluronic acid, platelet-rich plasma or both in association?

Bibliography

• Aigner T, Kim HA. Apoptosis and cellular vitality: issues in osteoarthritic cartilage degeneration. Arthritis Rheum 2002;46(8):1986-96
   PubMed Web of Science ®Google Scholar
• Divine JG, Zazulak BT, Wewett TE. Viscosupplementation for knee osteoarthritis. Clin Orthop Relat Res 2006;455:113-22
   Web of Science ®Google Scholar
• Hiligsmann M, Cooper C, Arden N, et al. Health economics in the field of osteoarthritis: an Expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Semin Arthritis Rheum 2013;43(3):303-13
   PubMed Web of Science ®Google Scholar
• Bondeson J. Are we moving in the right direction with osteoarthritis drug discovery? Expert Opin Ther Targets 2011;15(12):1355-68
   PubMed Web of Science ®Google Scholar
• Briggs KK, Matheny LM, Steadman JR. Can Hylan G-F 20 with corticosteroid meet the expectations of osteoarthritis patients? Am J Orthop (Belle Mead NJ) 2012;41(7):311-15
   PubMedGoogle Scholar
• Andia I, Sánchez M, Maffulli N. Joint pathology and platelet-rich plasma therapies. Expert Opin Biol Ther 2012;12(1):7-22
   PubMed Web of Science ®Google Scholar
• Reitinger S, Lepperdinger G. Hyaluronan, a ready choice to fuel regeneration: a mini review. Gerontology 2013;59:71-6
   PubMed Web of Science ®Google Scholar
• Musumeci G, Loreto C, Carnazza ML, et al. Acute injury affects lubricin expression in knee menisci: an immunohistochemical study. Ann Anat 2013;195(2):151-8
   PubMed Web of Science ®Google Scholar
• Itano N, Kimata K. Expression cloning and molecular characterization of HAS protein, a eukaryotic hyaluronan synthase. J Biol Chem 1996;271(17):9875-8
   PubMed Web of Science ®Google Scholar
• Weigel PH, Hascall VC, Tammi M. Hyaluronan synthases. J Biol Chem 1997;272(22):13997-4000
   PubMed Web of Science ®Google Scholar
• Kvam C, Granese D, Flaibani A, et al. Purification and characterization of hyaluronan from synovial fluid. Anal Biochem 1993;211(1):44-9
   PubMed Web of Science ®Google Scholar
• David-Raoudi M, Deschrevel B, Leclercq S, et al. Chondroitin sulfate increases hyaluronan production by human synoviocytes through differential regulation of hyaluronan synthases: role of p38 and Akt. Arthritis Rheum 2009;60(3):760-70
   PubMed Web of Science ®Google Scholar
• Meran S, Martin J, Luo DD, et al. Interleukin-1beta induces hyaluronan and CD44-dependent cell protrusions that facilitate fibroblast-monocyte binding. Am J Pathol 2013;182(6):2223-40
   PubMed Web of Science ®Google Scholar
• Muto J, Yamasaki K, Taylor KR, Gallo RL. Engagement of CD44 by hyaluronan suppresses TLR4 signaling and the septic response to LPS. Mol Immunol 2009;47(2-3):449-56
   PubMed Web of Science ®Google Scholar
• Bollyky PL, Falk BA, Wu RP, et al. Intact extracellular matrix and the maintenance of immune tolerance: high molecular weight hyaluronan promotes persistence of induced CD4+CD25+ regulatory T cells. J Leukoc Biol 2009;86(3):567-72
   PubMed Web of Science ®Google Scholar
• Myint P, Deeble DJ, Beaumont PC, et al. The reactivity of various free radicals with hyaluronic acid: steady-state and pulse radiolysis studies. Biochim Biophys Acta 1987;925(2):194-202
   PubMed Web of Science ®Google Scholar
• Ono Y, Sakai T, Hiraiwa H, et al. Chondrogenic capacity and alterations in hyaluronan synthesis of cultured human osteoarthritic chondrocytes. Biochem Biophys Res Commun 2013;435(4):733-9
   PubMed Web of Science ®Google Scholar
• Scheibner KA, Lutz MA, Boodoo S, et al. Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J Immunol 2006;177(2):1272-81
   PubMed Web of Science ®Google Scholar
• Campo GM, Avenoso A, D'Ascola A, et al. 4-mer hyaluronan oligosaccharides stimulate inflammation response in synovial fibroblasts in part via TAK-1 and in part via p38-MAPK. Curr Med Chem 2013;20(9):1162-72
   PubMed Web of Science ®Google Scholar
• Campo GM, Avenoso A, D'Ascola A, et al. Adenosine A2A receptor activation and hyaluronan fragment inhibition reduce inflammation in mouse articular chondrocytes stimulated with interleukin-1beta. FEBS J 2012;279(12):2120-33
   PubMed Web of Science ®Google Scholar
• Abate M, Pulcini D, Di Iorio A, Schiavone C. Viscosupplementation with intra-articular hyaluronic acid for treatment of osteoarthritis in the elderly. Curr Pharm Des 2010;16(6):631-40
   PubMed Web of Science ®Google Scholar
• Csoka AB, Stern R. Hypotheses on the evolution of hyaluronan: a highly ironic acid. Glycobiology 2013;23(4):398-411
   PubMed Web of Science ®Google Scholar
• Li J, Gorski DJ, Anemaet W, et al. Hyaluronan injection in murine osteoarthritis prevents TGFbeta 1-induced synovial neovascularization and fibrosis and maintains articular cartilage integrity by a CD44-dependent mechanism. Arthritis Res Ther 2012;14(3):R151
   Google Scholar
• Zhang FJ, Luo W, Gao SG, et al. Expression of CD44 in articular cartilage is associated with disease severity in knee osteoarthritis. Mod Rheumatol 2013;23(6):1186-91
   PubMed Web of Science ®Google Scholar
• Zhang FJ, Gao SG, Cheng L, et al. The effect of hyaluronic acid on osteopontin and CD44 mRNA of fibroblast-like synoviocytes in patients with osteoarthritis of the knee. Rheumatol Int 2013;33(1):79-83
   PubMed Web of Science ®Google Scholar
• Wang LS, Du C, Toh WS, et al. Modulation of chondrocyte functions and stiffness-dependent cartilage repair using an injectable enzymatically crosslinked hydrogel with tunable mechanical properties. Biomaterials 2014;35(7):2207-17
   PubMed Web of Science ®Google Scholar
• Zavan B, Ferroni L, Giorgi C, et al. Hyaluronic acid induces activation of the kappa-opioid receptor. PLoS One 2013;8(1):e55510
   Google Scholar
• Echeverry S, Wu Y, Zhang J. Selectively reducing cytokine/chemokine expressing macrophages in injured nerves impairs the development of neuropathic pain. Exp Neurol 2013;240:205-18
   PubMed Web of Science ®Google Scholar
• Ren K, Dubner R. Interactions between the immune and nervous systems in pain. Nat Med 2010;16(11):1267-76
   PubMed Web of Science ®Google Scholar
• Bagga H, Burkhardt D, Sambrook P, March L. Longterm effects of intraarticular hyaluronan on synovial fluid in osteoarthritis of the knee. J Rheumatol 2006;33(5):946-50
   PubMed Web of Science ®Google Scholar
• Migliore A, Giovannangeli F, Granata M, Laganà B. Hylan g-f 20: review of its safety and efficacy in the management of joint pain in osteoarthritis. Clin Med Insights Arthritis Musculoskelet Disord 2010;3:55-68
   PubMedGoogle Scholar
• Waddell DD. Viscosupplementation with hyaluronans for osteoarthritis of the knee: clinical efficacy and economic implications. Drugs Aging 2007;24(8):629-42
   PubMed Web of Science ®Google Scholar
• Berg P, Olsson U. Intra-articular injection of non-animal stabilised hyaluronic acid (NASHA) for osteoarthritis of the hip: a pilot study. Clin Exp Rheumatol 2004;22(3):300-6
   PubMed Web of Science ®Google Scholar
• Evans CH, Kraus VB, Setton LA. Progress in intra-articular therapy. Nat Rev Rheumatol 2013, doi: 10.1038/nrrheum.2013.159
   PubMed Web of Science ®Google Scholar
• Borrás-Verdera A, Calcedo-Bernal V, Ojeda-Levenfeld J, Clavel-Sainz C. [Efficacy and safety of a single intra-articular injection of 2% hyaluronic acid plus mannitol in knee osteoarthritis over a 6-month period]. Rev Esp Cir Ortop Traumatol 2012;56(4):274-80
   Google Scholar
• Morgen M, Tung D, Boras B, et al. Nanoparticles for improved local retention after intra-articular injection into the knee joint. Pharm Res 2013;30(1):257-68
   PubMed Web of Science ®Google Scholar
• Henrotin Y, Hauzeur JP, Bruel P, Appelboom T. Intra-articular use of a medical device composed of hyaluronic acid and chondroitin sulfate (Structovial CS): effects on clinical, ultrasonographic and biological parameters. BMC Res Notes 2012;5:407
   PubMedGoogle Scholar
• Heisel J, Kipshoven C. Safety and efficacy findings from a non-interventional study of a new hyaluronic acid/sorbitol formulation (GO-ON® matrix) for intra-articular injection to relieve pain and disability in osteoarthritis patients. Drug Res (Stuttg) 2013;63(9):445-9
   Google Scholar
• Dong J, Jiang D, Wang Z, et al. Intra-articular delivery of liposomal celecoxib-hyaluronate combination for the treatment of osteoarthritis in rabbit model. Int J Pharm 2013;441(1-2):285-90
   PubMed Web of Science ®Google Scholar
• Wang J, Yuan Y, Liu C, et al. Preparation and pharmaceutical/pharmacodynamic evaluation of topical brucine-loaded liposomal hydrogel. J Mater Sci Mater Med 2009;20(10):2075-84
   PubMed Web of Science ®Google Scholar
• Lu HT, Sheu MT, Lin YF, et al. Injectable hyaluronic-acid-doxycycline hydrogel therapy in experimental rabbit osteoarthritis. BMC Vet Res 2013;9:68
   PubMedGoogle Scholar
• Takahashi D, Majima T, Onodera T, et al. Celecoxib does not affect the release of hyaluronic acid in end stage osteoarthritic joints. Mod Rheumatol 2013;23(5):934-8
   PubMed Web of Science ®Google Scholar
• Hunter DJ, Lo GH. The management of osteoarthritis: an overview and call to appropriate conservative treatment. Rheum Dis Clin North Am 2008;34(3):689-712
   PubMed Web of Science ®Google Scholar
• Campbell J, Bellamy N, Gee T. Differences between systematic reviews/meta-analyses of hyaluronic acid/hyaluronan/hylan in osteoarthritis of the knee. Osteoarthritis Cartilage 2007;15(12):1424-36
   PubMed Web of Science ®Google Scholar
• Miller LE, Block JE. US-approved intra-articular hyaluronic acid injections are safe and effective in patients with knee osteoarthritis: systematic review and meta-analysis of randomized, saline-controlled trials. Clin Med Insights Arthritis Musculoskelet Disord 2013;6:57-63
   PubMedGoogle Scholar
• Aggarwal A, Sempowski IP. Hyaluronic acid injections for knee osteoarthritis. Systematic review of the literature. Can Fam Physician 2004;50:249-56
   PubMed Web of Science ®Google Scholar
• Divine JG, Shaffer MD. Use of viscosupplementation for knee osteoarthritis: an update. Curr Sports Med Rep 2011;10(5):279-84
   PubMed Web of Science ®Google Scholar
• Waddell DD. Viscosupplementation with hyaluronans for osteoarthritis of the knee: clinical efficacy and economic implications. Drugs Aging 2007;24(8):629-42
   PubMed Web of Science ®Google Scholar
• Rutjes AW, Jüni P, da Costa BR, et al. Viscosupplementation for osteoarthritis of the knee: a systematic review and meta-analysis. Ann Intern Med 2012;157(3):180-91
   PubMed Web of Science ®Google Scholar
• Colen S, van den Bekerom MP, Mulier M, Haverkamp D. Hyaluronic acid in the treatment of knee osteoarthritis: a systematic review and meta-analysis with emphasis on the efficacy of different products. BioDrugs 2012;26(4):257-68
   PubMed Web of Science ®Google Scholar
• Uçar D, Dıraçoğlu D, Süleyman T, Capan N. Intra-articular hyaluronic Acid as treatment in elderly and middle-aged patients with knee osteoarthritis. Open Rheumatol J 2013;7:38-41
   PubMedGoogle Scholar
• Bannuru RR, Natov NS, Dasi UR, et al. Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis-meta-analysis. Osteoarthritis Cartilage 2011;19(6):611-19
   PubMed Web of Science ®Google Scholar
• Dagenais S. Intra-articular hyaluronic acid (viscosupplementation) for knee osteoarthritis. Issues Emerg Health Technol 2006;94:1-4
   PubMedGoogle Scholar
• Henrotin Y, Chevalier X, Deberg M, et al.; Osteoarthritis Group of French Society of Rheumatology. Early decrease of serum biomarkers of type II collagen degradation (Coll2-1) and joint inflammation (Coll2-1 NO2) by hyaluronic acid intra-articular injections in patients with knee osteoarthritis: a research study part of the Biovisco study. J Orthop Res 2013;31(6):901-7
   PubMed Web of Science ®Google Scholar
• Andia I, Abate M. Platelet-rich plasma: underlying biology and clinical correlates. Regen Med 2013;8(5):645-58
   PubMed Web of Science ®Google Scholar
• Andia I, Maffulli N. Platelet-rich plasma for managing pain and inflammation in osteoarthritis. Nat Rev Rheumatol 2013;9(12):721-30
   PubMed Web of Science ®Google Scholar
• Karystinou A, Dell'Accio F, Kurth TB, et al. Distinct mesenchymal progenitor cell subsets in the adult human synovium. Rheumatology (Oxford) 2009;48(9):1057-64
   PubMed Web of Science ®Google Scholar
• Manferdini C, Maumus M, Gabusi E, et al. Adipose-derived mesenchymal stem cells exert antiinflammatory effects on chondrocytes and synoviocytes from osteoarthritis patients through prostaglandin E2. Arthritis Rheum 2013;65(5):1271-81
   PubMed Web of Science ®Google Scholar
• de Vries-van Melle ML, Narcisi R, Kops N, et al. Chondrogenesis of mesenchymal stem cells in an osteochondral environment is mediated by the subchondral bone. Tissue Eng Part A 2013;20(1-2):23-33
   PubMed Web of Science ®Google Scholar
• Murphy MB, Blashki D, Buchanan RM, et al. Adult and umbilical cord blood-derived platelet-rich plasma for mesenchymal stem cell proliferation, chemotaxis, and cryo-preservation. Biomaterials 2012;33(21):5308-16
   PubMed Web of Science ®Google Scholar
• Anitua E, Sanchez M, De la Fuente M, et al. Plasma rich in growth factors (PRGF-Endoret) stimulates tendon and synovial fibroblasts migration and improves the biological properties of hyaluronic acid. Knee Surg Sports Traumatol Arthrosc 2012;20(9):1657-65
   PubMed Web of Science ®Google Scholar
• Krüger JP, Hondke S, Endres M, et al. Human platelet-rich plasma stimulates migration and chondrogenic differentiation of human subchondral progenitor cells. J Orthop Res 2012;30(6):845-52
   PubMed Web of Science ®Google Scholar
• Kulawig R, Krüger JP, Klein O, et al. Identification of fibronectin as a major factor in human serum to recruit subchondral mesenchymal progenitor cells. Proc Natl Acad Sci USA 2013;110(12):4563-8
   PubMedGoogle Scholar
• Martino MM, Briquez PS, Ranga A, et al. Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix. Int J Biochem Cell Biol 2013;45(7):1410-18
   PubMedGoogle Scholar
• Vaz R, Martins GG, Thorsteinsdóttir S, Rodrigues G. Fibronectin promotes migration, alignment and fusion in an in vitro myoblast cell model. Cell Tissue Res 2012;348(3):569-78
   PubMed Web of Science ®Google Scholar
• Brown AC, Barker TH. Fibrin-based biomaterials: modulation of macroscopic properties through rational design at the molecular level. Acta Biomater 2013. [Epub ahead of print]
   Web of Science ®Google Scholar
• Anitua E, Sánchez M, Nurden AT, et al. Platelet-released growth factors enhance the secretion of hyaluronic acid and induce hepatocyte growth factor production by synovial fibroblasts from arthritic patients. Rheumatology (Oxford) 2007;46(12):1769-72
   PubMed Web of Science ®Google Scholar
• Drengk A, Zapf A, Stürmer EK, et al. Influence of platelet-rich plasma on chondrogenic differentiation and proliferation of chondrocytes and mesenchymal stem cells. Cells Tissues Organs 2009;189(5):317-26
   PubMed Web of Science ®Google Scholar
• Schallmoser K, Bartmann C, Rohde E, et al. Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion 2007;47(8):1436-46
   PubMed Web of Science ®Google Scholar
• Bieback K, Hecker A, Kocaömer A, et al. Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells 2009;27(9):2331-41
   PubMed Web of Science ®Google Scholar
• Harrison S, Vavken P, Kevy S, et al. Platelet activation by collagen provides sustained release of anabolic cytokines. Am J Sports Med 2011;39(4):729-34
   PubMed Web of Science ®Google Scholar
• Warnke PH, Humpe A, Strunk D, et al. A clinically-feasible protocol for using human platelet lysate and mesenchymal stem cells in regenerative therapies. J Craniomaxillofac Surg 2013;41(2):153-61
   PubMed Web of Science ®Google Scholar
• Prins HJ, Rozemuller H, Vonk-Griffioen S, et al. Bone-forming capacity of mesenchymal stromal cells when cultured in the presence of human platelet lysate as substitute for fetal bovine serum. Tissue Eng Part A 2009;15(12):3741-51
   PubMed Web of Science ®Google Scholar
• Kakudo N, Minakata T, Mitsui T, et al. Proliferation-promoting effect of platelet-rich plasma on human adipose-derived stem cells and human dermal fibroblasts. Plast Reconstr Surg 2008;122(5):1352-60
   PubMed Web of Science ®Google Scholar
• Griffiths S, Baraniak PR, Copland IB, et al. Human platelet lysate stimulates high-passage and senescent human multipotent mesenchymal stromal cell growth and rejuvenation in vitro. Cytotherapy 2013;15(12):1469-83
   PubMed Web of Science ®Google Scholar
• Krüger JP, Endres M, Neumann K, et al. Chondrogenic differentiation of human subchondral progenitor cells is affected by synovial fluid from donors with osteoarthritis or rheumatoid arthritis. J Orthop Surg Res 2012;7:10
   PubMedGoogle Scholar
• Kocaoember A, Kern S, Klüter H, Bieback K. Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells 2007;25(5):1270-8
   PubMed Web of Science ®Google Scholar
• Spreafico A, Chellini F, Frediani B, et al. Biochemical investigation of the effects of human platelet releasates on human articular chondrocytes. J Cell Biochem 2009;108(5):1153-65
   PubMed Web of Science ®Google Scholar
• Mishra A, Tummala P, King A, et al. Buffered platelet-rich plasma enhances mesenchymal stem cell proliferation and chondrogenic differentiation. Tissue Eng Part C Methods 2009;15(3):431-5
   PubMed Web of Science ®Google Scholar
• Shih DT, Chen JC, Chen WY, et al. Expansion of adipose tissue mesenchymal stromal progenitors in serum-free medium supplemented with virally inactivated allogeneic human platelet lysate. Transfusion 2011;51(4):770-8
   PubMed Web of Science ®Google Scholar
• Hildner F, Eder MJ, Hofer K, et al. Human platelet lysate successfully promotes proliferation and subsequent chondrogenic differentiation of adipose-derived stem cells: a comparison with articular chondrocytes. J Tissue Eng Regen Med 2013, doi: 10.1002/term.1649
   PubMedGoogle Scholar
• Lange C, Cakiroglu F, Spiess AN, et al. Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine. J Cell Physiol 2007;213(1):18-26
   PubMed Web of Science ®Google Scholar
• Horn P, Bokermann G, Cholewa D, et al. Impact of individual platelet lysates on isolation and growth of human mesenchymal stromal cells. Cytotherapy 2010;12(7):888-98
   PubMed Web of Science ®Google Scholar
• Gottipamula S, Sharma A, Krishnamurthy S, et al. Human platelet lysate is an alternative to fetal bovine serum for large-scale expansion of bone marrow-derived mesenchymal stromal cells. Biotechnol Lett 2012;34(7):1367-74
   PubMed Web of Science ®Google Scholar
• Flemming A, Schallmoser K, Strunk D, et al. Immunomodulative efficacy of bone marrow-derived mesenchymal stem cells cultured in human platelet lysate. J Clin Immunol 2011;31(6):1143-56
   PubMed Web of Science ®Google Scholar
• Cho HS, Song IH, Park SY, et al. Individual variation in growth factor concentrations in platelet-rich plasma and its influence on human mesenchymal stem cells. Korean J Lab Med 2011;31(3):212-18
   PubMed Web of Science ®Google Scholar
• Lohmann M, Walenda G, Hemeda H, et al. Donor age of human platelet lysate affects proliferation and differentiation of mesenchymal stem cells. PLoS One 2012;7(5):e37839
   PubMed Web of Science ®Google Scholar
• Zhu Y, Yuan M, Meng HY, et al. Basic science and clinical application of platelet-rich plasma for cartilage defects and osteoarthritis: a review. Osteoarthritis Cartilage 2013;21(11):1627-37
   PubMed Web of Science ®Google Scholar
• Milano G, Sanna Passino E, Deriu L, et al. The effect of platelet rich plasma combined with microfractures on the treatment of chondral defects: an experimental study in a sheep model. Osteoarthritis Cartilage 2010;18(7):971-80
   PubMed Web of Science ®Google Scholar
• Milano G, Deriu L, Sanna Passino E, et al. Repeated platelet concentrate injections enhance reparative response of microfractures in the treatment of chondral defects of the knee: an experimental study in an animal model. Arthroscopy 2012;28(5):688-701
   PubMed Web of Science ®Google Scholar
• Kwon DR, Park GY, Lee SU. The effects of intra-articular platelet-rich plasma injection according to the severity of collagenase-induced knee osteoarthritis in a rabbit model. Ann Rehabil Med 2012;36(4):458-65
   PubMedGoogle Scholar
• Saito M, Takahashi KA, Arai Y, et al. Intraarticular administration of platelet-rich plasma with biodegradable gelatin hydrogel microspheres prevents osteoarthritis progression in the rabbit knee. Clin Exp Rheumatol 2009;27(2):201-7
   PubMed Web of Science ®Google Scholar
• Guner S, Buyukbebeci O. Analyzing the effects of platelet gel on knee osteoarthritis in the rat model. Clin Appl Thromb Hemost 2013;19(5):494-8
   PubMed Web of Science ®Google Scholar
• Filardo G, Kon E, Roffi A, et al. Platelet-rich plasma: why intra-articular? A systematic review of preclinical studies and clinical evidence on PRP for joint degeneration. Knee Surg Sports Traumatol Arthrosc 2013. [Epub ahead of print]
   Google Scholar
• Vaquerizo V, Plasencia MA, Arribas I, et al. Comparison of intra-articular injections of plasma rich in growth factors (PRGF-Endoret) versus Durolane hyaluronic acid in the treatment of patients with symptomatic osteoarthritis: a randomized controlled trial. Arthroscopy 2013;29(10):1635-43
   PubMed Web of Science ®Google Scholar
• Sánchez M, Fiz N, Azofra J, et al. A randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis. Arthroscopy 2012;28(8):1070-8
   PubMed Web of Science ®Google Scholar
• Patel S, Dhillon MS, Aggarwal S, et al. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Am J Sports Med 2013;41(2):356-64
   PubMed Web of Science ®Google Scholar
• Cerza F, Carnì S, Carcangiu A, et al. Comparison between hyaluronic acid and platelet-rich plasma, intra-articular infiltration in the treatment of gonarthrosis. Am J Sports Med 2012;40(12):2822-7
   PubMed Web of Science ®Google Scholar
• Filardo G, Kon E, Pereira Ruiz MT, et al. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single- versus double-spinning approach. Knee Surg Sports Traumatol Arthrosc 2012;20(10):2082-91
   PubMed Web of Science ®Google Scholar
• Spaková T, Rosocha J, Lacko M, et al. Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid. Am J Phys Med Rehabil 2012;91(5):411-17
   PubMed Web of Science ®Google Scholar
• Kon E, Mandelbaum B, Buda R, et al. Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis. Arthroscopy 2011;27(11):1490-501
   PubMed Web of Science ®Google Scholar
• Sánchez M, Anitua E, Azofra J, et al. Intra-articular injection of an autologous preparation rich in growth factors for the treatment of knee OA: a retrospective cohort study. Clin Exp Rheumatol 2008;26(5):910-13
   PubMed Web of Science ®Google Scholar
• Wang-Saegusa A, Cugat R, Ares O, et al. Infiltration of plasma rich in growth factors for osteoarthritis of the knee short-term effects on function and quality of life. Arch Orthop Trauma Surg 2011;131(3):311-17
   PubMed Web of Science ®Google Scholar
• Sampson S, Reed M, Silvers H, et al. Injection of platelet-rich plasma in patients with primary and secondary knee osteoarthritis: a pilot study. Am J Phys Med Rehabil 2010;89(12):961-9
   PubMed Web of Science ®Google Scholar
• Napolitano M, Matera S, Bossio M, et al. Autologous platelet gel for tissue regeneration in degenerative disorders of the knee. Blood Transfus 2012;10(1):72-7
   PubMed Web of Science ®Google Scholar
• Kon E, Buda R, Filardo G, et al. Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surg Sports Traumatol Arthrosc 2010;18:472-9
   PubMed Web of Science ®Google Scholar
• Gobbi A, Karnatzikos G, Mahajan V, Malchira S. Platelet-rich plasma treatment in symptomatic patients with knee osteoarthritis: preliminary results in a group of active patients. Sports Health 2012;4(2):162-72
   PubMedGoogle Scholar
• Halpern B, Chaudhury S, Rodeo SA, et al. Clinical and MRI outcomes after platelet-rich plasma treatment for knee osteoarthritis. Clin J Sport Med 2013;23(3):238-9
   PubMed Web of Science ®Google Scholar
• Jang SJ, Kim JD, Cha SS. Platelet-rich plasma (PRP) injections as an effective treatment for early osteoarthritis. Eur J Orthop Surg Traumatol 2013;23(5):573-80
   PubMedGoogle Scholar
• Khoshbin A, Leroux T, Wasserstein D, et al. The efficacy of platelet-rich plasma in the treatment of symptomatic knee osteoarthritis: a systematic review with quantitative synthesis. Arthroscopy 2013;29(12):2037-48
   PubMed Web of Science ®Google Scholar
• Chang K-V, Hung Ch-Y, Aliwarga F, et al. Comparative effectiveness of platelet-rich plasma injections for treating knee joint cartilage degenerative pathology. A systematic review and meta-analysis. Arch Phys Med Rehabil 2013; Epub ahead of print
   Web of Science ®Google Scholar
• Baltzer AW, Moser C, Jansen SA, Krauspe R. Autologous conditioned serum (Orthokine) is an effective treatment for knee osteoarthritis. Osteoarthritis Cartilage 2009;17(2):152-60
   PubMed Web of Science ®Google Scholar
• Krüger JP, Freymann U, Vetterlein S, et al. Bioactive factors in platelet-rich plasma obtained by apheresis. Transfus Med Hemother 2013;40:432-40
   PubMed Web of Science ®Google Scholar
• Sundman EA, Cole BJ, Karas V, et al. The anti-inflammatory and matrix restorative mechanisms of platelet-rich plasma in osteoarthritis. Am J Sports Med 2013;42(1):35-41
   PubMed Web of Science ®Google Scholar
• Marmotti A, Bruzzone M, Bonasia DE, et al. One-step osteochondral repair with cartilage fragments in a composite scaffold. Knee Surg Sports Traumatol Arthrosc 2012;20(12):2590-601
   PubMed Web of Science ®Google Scholar
• Srinivasan PP, McCoy SY, Jha AK, et al. Injectable perlecan domain 1-hyaluronan microgels potentiate the cartilage repair effect of BMP2 in a murine model of early osteoarthritis. Biomed Mater 2012;7(2):024109
   Web of Science ®Google Scholar
• Cervelli V, Lucarini L, Spallone D, et al. Use of platelet-rich plasma and hyaluronic acid in the loss of substance with bone exposure. Adv Skin Wound Care 2011;24(4):176-81
   PubMed Web of Science ®Google Scholar
• Nicoli F, Balzani A, Lazzeri D, et al. Severe hidradenitis suppurativa treatment using platelet-rich plasma gel and Hyalomatrix. Int Wound J 2013. [Epub ahead of print]
   PubMedGoogle Scholar
• Yamada Y, Nakamura S, Ueda M, Ito K. Papilla regeneration by injectable stem cell therapy with regenerative medicine: long-term clinical prognosis. J Tissue Eng Regen Med 2013. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• De Angelis B, Lucarini L, Orlandi F, et al. Regenerative surgery of the complications with Morton's neuroma surgery: use of platelet rich plasma and hyaluronic acid. Int Wound J 2013;10(4):372-6
   PubMedGoogle Scholar
• Sánchez M, Azofra J, Anitua E, et al. Plasma rich in growth factors to treat an articular cartilage avulsion: a case report. Med Sci Sports Exerc 2003;35(10):1648-52
   PubMed Web of Science ®Google Scholar